NCT
HOME CURRENT ARCHIVE COVID-19
HOME CURRENT ARCHIVE PUBLISH INSTRUCTIONS
FOR AUTHORS COVID-19 LOG IN / REGISTER HISTORY ABOUT US DIRECTORY CONTACT
Refractory pleural effusion in the children with systemic lupus erythematosus. A case study

Sancho-Hernández, Rogelio; Gutiérrez-Morales, Gabriel; Cuevas-Schacht, Francisco Javier





2014, Number 4

2014; 73 (4)






ABSTRACT

We report the case of a 14 year old with massive bilateral pleural effusion in the course of systemic lupus erythematosus refractory to steroid and immunosuppressive therapy; the review of literature in children is described and current therapeutic options are discussed.

KEYWORDS

Refractory pleural effusion, systemic lupus erythematosus, treatment options.

REFERENCES

  1. Bouros D, Pneumatikos I, Tzouvelekis A. Pleural involvement in systemic autoimmune disorders. Respiration 2008;75(4):361-371. doi: 10.1159/000119051.

  2. Bouros D, Panagou P, Papandreou L, Kottakis I, Tegos C. Massive bilateral pleural effusion as the only first presentation of systemic lupus erythematosus. Respiration 1992;59(3):173-175.

  3. Pohlgeers AP, Eid NS, Schikler KN, Shearer LT. Systemic lupus erythematosus: pulmonary presentation in childhood. South Med J 1990;83(6):712-714.

  4. Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 1981;71(5):791-798.

  5. Quismorio FP Jr. Clinical and pathologic features of lung involvement in systemic lupus erythematosus. Semin Respir Dis 1988;9:297.

  6. Nadorra RL, Landing BH. Pulmonary lesions in childhood onset systemic lupus erythematosus: analysis of 26 cases, and summary of literature. Pediatr Pathol 1987;7(1):1-18.

  7. Chantarojanasiri T, Sittirath A, Preutthipan A, Tapaneya-Olarn W, Suwanjutha S. Pulmonary involvement in childhood systemic lupus erythematosus. J Med Assoc Thai 1999;82 Suppl 1:S144-S148.

  8. Walz-Leblanc BA, Urowitz MB, Gladman DD, Hanly PJ. The “shrinking lungs syndrome” in systemic lupus erythematosus improvement with corticosteroid therapy. J Rheumatol 1992;19(12):1970-1972.

  9. Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE a clinical pathologic study. J Rheumatol 1983;10(6):973-976.

  10. Winslow WA, Ploss LN, Loitman B. Pleuritis in systemic lupus erythematosus: its importance as an early manifestation in diagnosis. Ann Intern Med 1958;49(1):70-88.

  11. Alarcón-Segovia D, Alarcón DG. Pleuro-pulmonary manifestations of systemic lupus erythematosus. Dis Chest 1961;39:7-17.

  12. Caeiro F, Michielson FM, Bernstein R, Hughes GR, Ansell BM. Systemic lupus erythematosus in childhood. Ann Rheum Dis 1981;40(4):325-331.

  13. de Jongste JC, Neijens HJ, Duiverman EJ, Bogaard JM, Kerrebijn KF. Respiratory tract disease in systemic lupus erythematosus. Arch Dis Child 1986;61(5):478-483.

  14. Chandrasekhar AJ, Robinson J, Barr L. Antibody deposition in the pleura: a finding in drug-induced lupus. J Allergy Clin Immunol 1978;61(6):399-402.

  15. Khare V, Baethge B, Lang S, Wolf RE, Campbell GD Jr. Antinuclear antibodies in pleural fluid. Chest 1994;106(3):866-871.

  16. Pertschuk LP, Moccia LF, Rosen Y, et al. Acute pulmonary complications in systemic lupus erythematosus. Immunofluorescence and light microscopic study. Am J Clin Pathol 1977;68(5):553-557.

  17. Keane MP, Lynch JP 3rd. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000;55(2):159-166.

  18. Brasington RD, Furst DE. Pulmonary disease in systemic lupus erythematosus. Clin Exp Rheumatol 1985;3(3):269-276.

  19. Sherer Y, Langevitz P, Levy Y, Fabrizzi F, Shoenfeld Y. Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin. Lupus 1999;8(4):324-327.

  20. McKnight KM, Adair NE, Agudelo CA. Successful use of tetracycline pleurodesis to treat massive pleural effusion secondary to systemic lupus erythematosus. Arthritis Rheum 1991;34(11):1483-1484.

  21. Kaine JL. Refractory massive pleural effusion in systemic lupus erythematosus treated with talc poudrage. Ann Rheum Dis 1985;44(1):61-64.

  22. Gilleece MH, Evans CC, Bucknall RC. Steroid resistant pleural effusion in systemic lupus erythematosus treated with tetracycline pleurodesis. Ann Rheum Dis 1988;47(12):1031-1032.

  23. D’Cruz D, Khamashta M, Hughes G. Pulmonary manifestations of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois lupus erythematosus. 6th ed. Philadelphia, Lippincott: Williams and Wilkins; 2002. p. 663-684.

  24. Cardillo G, Facciolo F, Carbone L, et al. Long-term follow up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothorac Surg 2002;21(2):302-305.

  25. Saffran L, Ost DE, Fein AM, Schiff MJ. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest 2000;118(2):417-421.

  26. Anderson CB, Philpott GW, Ferguson TB. The treatment of malignant pleural effusions. Cancer 1974;33(4):916-922.

  27. Parulekar W, Di Primio G, Matzinger F, Dennie C, Bociek G. Use of small- bore vs. large bore chest tubes for treatment of malignant pleural effusions. Chest 2001;120(1):19-25.

  28. Grossi F, Pennucci MC, Tixi L, Cafferata MA, Ardizzoni A. Management of malignant pleural effusions. Drug 1998;55(1):47-58.

  29. Petrou M, Kaplan D, Goldstraw P. Management of recurrent malignant pleural effusions. The complementary role talc pleurodesis and pleuroperitoneal shunting. Cancer 1995;75(3):801-805.

  30. Breuer GS, Deeb M, Fisher D, Nesher G. Therapeutic options for refractory massive pleural effusion in systemic lupus erythematosus: a case study and review of the literature. Semin Arthritis Rheum 2005;34(5):744-749.

  31. de Campos JR, Vargas FS, de Campos WE, et al. Thoracoscopy talc poudrage: a 15 year experience. Chest 2001;119(3):801-806.

  32. Bondoc AY, Bach PB, Sklarin NT, Vander Els NJ. Arterial desaturation syndrome following pleurodesis with talc slurry: incidence, clinical features, and outcome. Cancer Invest 2003;21(6):848-454.

  33. Rehse DH, Aye RW, Florence MG. Respiratory failure following talc pleurodesis. Am J Surg 1999;177(5):437-440.

  34. Mohsen TA, Zeid AA, Meshref M, et al. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial. Eur J Cardthorac Surg 2011;40(2):282-286. doi: 10.1016/j.ejcts.2010.09.005.

  35. Olivares-Torres CA, Laniado-Laborín R, Chávez-García C, León-Gastelum C, Reyes-Escamilla A, Light RW. Iodopovidone pleurodesis for recurrent pleural effusions. Chest 2002;122(2):581-583.

  36. Kelly-García J, Roman-Berumen JF, Ibarra-Pérez C. Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms. Arch Med Res 1997;28(4):583-585.

  37. Schulze M, Boehle AS, Kurdow R, Dohrmann P, Henne-Bruns D. Effective treatment of malignant pleural effusions by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg 2001;71(6):1809-1812.

  38. Elborn JS, Conn P, Roberts SD. Refractory massive pleural effusions in systemic lupus erythematosus treated by pleurectomy. Ann Rheum Dis 1987;46(1):77-80.

  39. Martini N, Bains MS, Beattie EJ Jr. Indications for pleurectomy in malignant effusion. Cancer 1975;35(3):734-738.

  40. Bell R, Lawrence DS. Chronic pleurisy in systemic lupus erythematosus treated with pleurectomy. Br J Dis Chest 1979;73(3):314-316.


2014, Number 4

2014; 73 (4)